Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bauer

Showing results (901-910 of 985) with videos related to

Pageof 99
Sort By:
Shock (Augusta, Ga.)|August 15, 2018
Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in SepsisMarcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Journal of Clinical Immunology|February 28, 2015
Infectious and immunologic phenotype of MECP2 duplication syndromeMichael Bauer, Uwe Kölsch, Renate Krüger, et al.
Schizophrenia Bulletin|July 20, 2022
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With SchizophreniaStephan Heres, Joachim Cordes, Sandra Feyerabend, et al.
Intensive Care Medicine Experimental|August 17, 2018
Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsisMarcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Pharmacopsychiatry|November 9, 2023
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot SurveyJuliane K Mueller, Kira F Ahrens, Michael Bauer, et al.
Bipolar Disorders|August 14, 2025
Defining Treatment-Resistant Bipolar Depression: Recommendations From the ISBD Task ForceEduard Vieta, Roger S McIntyre, Trisha Suppes, et al.
The Lancet. Infectious Diseases|October 22, 2019
Current gaps in sepsis immunology: new opportunities for translational researchIgnacio Rubio, Marcin F Osuchowski, Manu Shankar-Hari, et al.
Trials|February 6, 2019
Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-TrialPatrick Meybohm, Simone Lindau, Sascha Treskatsch, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 5, 2021
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic reviewEva Z Reininghaus, Mirko Manchia, Nina Dalkner, et al.
Pageof 99

Showing results (901-910 of 985) with videos related to

Sort By:
Pageof 99
Shock (Augusta, Ga.)|August 15, 2018
Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in SepsisMarcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Journal of Clinical Immunology|February 28, 2015
Infectious and immunologic phenotype of MECP2 duplication syndromeMichael Bauer, Uwe Kölsch, Renate Krüger, et al.
Schizophrenia Bulletin|July 20, 2022
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With SchizophreniaStephan Heres, Joachim Cordes, Sandra Feyerabend, et al.
Intensive Care Medicine Experimental|August 17, 2018
Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsisMarcin F Osuchowski, Alfred Ayala, Soheyl Bahrami, et al.
Pharmacopsychiatry|November 9, 2023
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot SurveyJuliane K Mueller, Kira F Ahrens, Michael Bauer, et al.
Bipolar Disorders|August 14, 2025
Defining Treatment-Resistant Bipolar Depression: Recommendations From the ISBD Task ForceEduard Vieta, Roger S McIntyre, Trisha Suppes, et al.
The Lancet. Infectious Diseases|October 22, 2019
Current gaps in sepsis immunology: new opportunities for translational researchIgnacio Rubio, Marcin F Osuchowski, Manu Shankar-Hari, et al.
Trials|February 6, 2019
Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients - the study design of the LIBERAL-TrialPatrick Meybohm, Simone Lindau, Sascha Treskatsch, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 19, 2026
Psychomotor slowing as a predictor of treatment outcomes in major depressive disorder with acute suicidality: Insights from the OASIS-D studyStefan Fritze, Iris Reinhard, Viktor B Nöhles, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 5, 2021
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic reviewEva Z Reininghaus, Mirko Manchia, Nina Dalkner, et al.
Pageof 99